Skip to content

Fibroblast-like synoviocytes and invasiveness in rheumatoid arthritis: Mechanistic insights and therapeutic implications

· 0 citations · 29 references

TL;DR

Understanding the crosstalk between cytoskeletal mechanics and inflammatory signalling may reveal novel regulatory mechanisms and identify promising therapeutic targets for rheumatoid arthritis.

View source

Similar papers

Review Open access Sep 2026

Targeting the NLRP3 inflammasome in rheumatoid arthritis fibroblast-like synoviocytes: pathogenic mechanisms, therapeutic strategies, and translational perspectives

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by persistent synovitis, pannus formation, cartilage degradation, and bone erosion. Although conventional synthetic, biologic, and targeted synthetic disease-modifying antirheumatic drugs have improved disease control, many patients fail t...

Lun-Min Bao, Hai-Bing Dai, Dao-Ming Wang et al. · 0 citations
Review Open access Aug 2026

Synovial immune control failure in osteoarthritis: from maintenance of tissue homeostasis to inflammatory niche formation

Osteoarthritis (OA) is a whole-joint disease involving cartilage, synovium, subchondral bone, and neurovascular structures. Synovitis, damage-associated molecular patterns, and interactions between macrophages and fibroblast-like synoviocytes have been widely studied. However, a tissue-level explanation is still lackin...

Kang-Yi Hu, Yong-Jia Song, Jia-Xing Pan et al. · 0 citations
Open access Sep 2026

MOLECULAR MECHANISMS OF CYTOKINE-INDUCED CARTILAGE DESTRUCTION IN RHEUMATOID ARTHRITIS

Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes long-term destruction of cartilage and leads to irreversible arthritis. Pro-inflammatory messengers such as interleukin-1 beta (IL-1 beta), tumour necrosis factor-alpha (TNF alpha), interleukin-6 (IL-6), and interleukin-17 (IL-17)—drive this destruct...

Subhendu Dey, Chayanika Goswami, Tanmay Mohanta et al. · 0 citations
Open access Sep 2026

CD248/Endosialin regulates synovial fibroblast state to control coupling of inflammation and bone damage in murine models of immune-mediated inflammatory arthritis and ageing.

The data suggests that the high levels of CD248 expression seen on synovial fibroblasts provides a protective brake that attenuates bone damage by preventing the polarisation of emergent fibroblasts towards a destructive phenotype.

Samuel Kemble, C. Wehmeyer, James M. Brown et al. · 0 citations
Conference Open access 2026

Research Progress on the Relationship between Joint Immune Microenvironment and Osteoarthritis Progression

Osteoarthritis (OA) has conventionally been considered a degenerative mechanical condition; but an increasing number of studies support an alternative perception of this disease as one characterized by impaired immune homeostasis in the joint environment. The purpose of this review is to analyze the mechanisms of how t...

Shu-Ze Si · 0 citations
Review Open access Sep 2026

When inflammation is not the driver: Pauci-immune synovitis and the stromal basis of refractory arthritis.

Approximately 5% to 20% of patients with rheumatoid arthritis (RA) fail to respond to sequential biologic and targeted synthetic disease-modifying antirheumatic drugs, representing a major unmet clinical need. Increasing evidence indicates that a substantial proportion of these patients exhibit a pauci-immune (fibroid)...

M. Elhai · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.